Salbutamol and theophylline are administered in combination orally to provide the sinergistic effect of drugs. The aim of this study is to develop and to validate ion pair liquid chromatography to determine both drugs in pharmaceutical dosage form, especialy in syrup. Separation of drugs was performed with Spherisorb C-18 column (250x4.6mm; 10um). The mobile phase used was the mixture of acetic acid 1% : methanol (60:40v/v) which contain 3.5mM sodium-1-octanesulphonate, as ion pairing reagent. The mobile phase was delivered isocratically with flow rate of 1mL/min. UV detection was set at the wavelength of 277nm. The developed method was validated in terms of linearity, precision, accuracy, selectivity, and sensitivity. The precision of the method was evaluated using repeatability assay having relative standard deviation (RSD) values of 0.41-0.70% for theophylline and 0.08-0.24% for salbutamol. The recovery percentages were in the range of 98.28-101.02%
ABSTRAC T
Salbutamol and theophylline are administered in combination orally to provide the sinergistic effect of drugs. The aim of this study is to develop and to validate ion pair liquid chromatography to determine both drugs in pharmaceutical dosage form, especialy in syrup. Separation of drugs was performed with Spherisorb C-18 column (250x4.6mm; 10um). The mobile phase used was the mixture of acetic acid 1% : methanol (60:40v/v) which contain 3.5mM sodium-1-octanesulphonate, as ion pairing reagent. The mobile phase was delivered isocratically with flow rate of 1mL/min. UV detection was set at the wavelength of 277nm. The developed method was validated in terms of linearity, precision, accuracy, selectivity, and sensitivity. The precision of the method was evaluated using repeatability assay having relative standard deviation (RSD) values of 0.41-0.70% for theophylline and 0.08-0.24% for salbutamol. The recovery percentages were in the range of 98.28-101.02%
(theophylline) and 100.71-101.60% for salbutamol. The developed method me t the validation requirement for analysis of salbutamol and theophylline simultaneously in syrup dosage form. Furthermore, the method also provided acceptable result for syrup and tablet dosage forms containing Salbutamol and theophylline only, and tablet containing the combination of Salbutamol and theophylline.
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INTRODUC TION
The combination of theophylline, 1, 3-dimethyl-7H-purine-2, 6-dione also known as dimethylxanthine as long-acting bronchodilator with Salbutamol, 4-[2-(tert-butylamino)-1-hydroxyethyl] -2-(hydroxymethyl) phenol, as short acting β-agonist is drug of choice for treatment of chronic obstructive pulmonary disease. Salbutamol and theophylline (Figure 1 Several methods have been reported for analysis of the individual of theophylline and salbutamol as well as their combination with other drugs in some dosage forms, namely ultraviolet spectrophotometry using multi-wavelength (Bhatia et al., 1998; Habib et al., 2005; Mishra et al., 2010) , thin layer chromatography using silica gel GF254 (Mirfazaelian et al., 2002; Hiral et al., 2010) , flow injection-spectrophotometric (Satinsky et al., 2002) . However, most methods used for analysis of both drugs are high performance liquid chromatography along with its variation, either in pharmaceutical dosage form or in biomedical fluid. Murthy dan Rani (2010) reported the analysis of transdermal dosage form containing both theophylline and salbutamol using reversed phase HPLC. Nagraju and Kaza (2009) reported HPLC for analysis of theophylline and salbutamol in bilayer sustained release. HPLC was also used for rapid analysis for the simultaneous quantification of theophylline and etophylline in human plasma (Nirogi et al., 2007) . Ramakrishna et al. (2007) used a simple and rapid HPLC/UV method for the simultaneous quantification of theophylline and etophylline in human plasma. HPLC was also used for analysis of theophylline and salbutamol either individual or in combination in some dosage forms as reported by Basu and Pathak (1990) , Marcia et al. (2002) , Nikola et al. (2003) , Ghulam et al. (2009), and Pai et al. (2009) .
Most of reported methods for analysis of theophylline and salbutamol used reversed phase HPLC coupled with several detectors. Using literature review, there is yet any report for determination of theophylline and salbutamol in syrup continously using ion pair HPLC. There, the aim of present work is to develop a valid ion-pair HPLC method for theophylline and salbutamol in syrup.
MATERIALS AND METHODS
Theophylline (Jilin Shulan Pharm., China) and salbutamol sulphate (Neuland, India) were kindly obtained from PT. Dexa Medica, Indonesia. Methanol used as mobile phase was HPLC grade. Sodium-1-octanesulfonate HPLC was obtained from JT. Baker, Germany. Aquadest and aquabidest were purchased from PT. Ikapharmindo and Brataco Chemical (Indonesia). The instrument used is HPLC (Shimadzu, Japan) equipped with pump LC 20 AD Sil 20A and detector UV-Vis SPD 20 A. Reagents and solvents used were of proanalytical grade. The dosage form samples were taken from drug store in Yogyakarta.
Chromatographic condition
Separation of theophylline and salbutamol was carried out using column Spherisorb C-18 (25x4.6mm i.d; 10µm). The mobile phase used was acetic acid 1%: methanol (60:40v/v) containing sodium-1-octanesulfonate 3.5mM as ion pair reagent. The mobile phase was delivered isocratically with flow rate of 1mL/min. UV detector was set at 277nm, and injection volume was 50μL. All analysis was carried out in ambient temperature.
Preparation of standard solution
Stock solution of theophylline (0.25mg/mL) and Salbutamol (0.25mg/mL) was prepared by dissolving 25mg theophylline and salbutamol separately in 100.0mL acetic acid 1%: methanol (60:40v/v). The working standard solutions were prepared by diluting 2.0mL stock solution of theophylline and 4.0mL stock solution of salbutamol with acetic acid 1%: methanol (60:40v/v) upto 50.0mL to obtain theophylline 10µg/mL and salbutamol 20µg/mL, respectively.
Sample preparation
Sample of syrup equivalent to 25mg theophylline and 1mg salbutamol was dissolved in 100.0mL 1% acetic acid: methanol (60:40v/v). A 2.0mL of this solution was diluted in 50mL volumetric flask and dissolved with 1% acetic acid: methanol (60:40 v/v). The solution was filtered using 0.45µm filter and injected into HPLC system.
Validation of analytical method
The developed analytical method was validated by assessing several parameters according to International Conference on Harmonization (2002), namely selectivity, linearity, precision, accuracy and sensitivity. The selectivity test was performed by observing the chromatogram of theophylline, salbutamol, samples and spiked samples. The linearity evaluation of theophylline was performed at level concentrations of 1, 5, 10, 15 and 20µg/mL, and at level concentration of 10, 15, 20, 25 and 30µg/mL for Salbutamol. Each concentration level was replicated 3 times. The precision study of theophylline and salbutamol was performed at level concentrations of 8, 10 and 12µg/mL, and at level of 16, 20 and 24µg/mL, respectively. Each level concentration was done in 6 replicates. Accuracy was performed by addition of known amount of theophylline and salbutamol standards to a known concentration of sample solution. The level concentration of theophylline for accuracy studies is at 1, 5, 10, 15, and 20ppm, and at levels of 10, 15, 20, 25 and 30ppm for salbutamol. Each level is subjected to 3 times replication. Sensitivity was evaluated by determining limit of detection and limit of quantitation, as determined by calculation based on linearity regresion (Miller and Miller, 2005) .
RESULT AND DISC USSION
Theophylline and salbutamol have N with nonbonding electron that contibute to the basic characteristic of drugs. The addition of acetic acid in the mobile phase will maximize the protonation process of both drugs. As a consequence, the protonated N-basic on theophylline and salbutamol will produce more polar property. Hydrophobic side from sodium-1-octanesulfonate as ion pairing reagent will interact with stationary phase of C-18, while the hydrophyllic side (SO3 -) can interact with the protonated N-basic on theophylline and salbutamol, and therefore, both drugs can be separated with acceptable resolution using the optimized HPLC condition.
The selectivity test showed that HPLC condition used had good separation, as indicated by resolution value (Rs) of > 2.0 (Figure 2) . The resolution of salbutamol to theophylline is around 15.55, while that of salbutamol to the closest peak is 2.61. Linearity studies revealed that the values of coefficient of correlation (r) for the relationship between concentration of drugs (x-axis) and peak area (y-axis) are > 0.99999 over concentration range of 1-20µg/mL for theophylline and 1-30µg/mL for salbutamol (Figure 3) . Furthermore, the % y-intercept obtained is 0.03% and 0.33% for theophylline and salbutamol, respectively, indicating low systematic error and could be negligible (Ahuja and Dong, 2005; Snyder et al., 2010) . From the values of r and %y-intercept, it could be concluded that the developed method were linear over the concentration ranges used.
The precision was determined by assessing the repeatability test of analytical method. Precision is usually measured as relative standard deviation (RSD) of a set of data. In this study, three levels, i.e. 80%, 100% and 120% from target value, corresponding to 8, 10 and 12 ppm (theophylline) and 16, 20 and 24ppm, were used. The RSD values obtained were 0.70%, 0.41%, and 0.42% (theophylline), and 0.21%, 0.09%, and 0.24% for salbutamol. According to Horwitz function, the maximum RSD value acceptable for the analyte level of 1ppm is 16%. AOAC set the maximum acceptable RSD value at 11% for the same analyte level (Gonzalez and Herrador 2007) . Therefore, it could be stated that the HPLC method showed good precision for analysis of theophylline and salbutamol based on RSD values obtained.
The accuracy of analytical method was determined using standard addition methods in which samples were added with standard solution of drugs in known amount in three different levels. The recovery values of drugs were assessed. The recovery value obtained for theophylline is 98.78-101.94 %, while that of salbutamol is 100.66-101.65%. According to AOAC as cited from Gonzalez and Herrador (2007) , the acceptable recovery percentage range is 80-110% for the analyte level of 1μg/mL. Therefore, the developed method was accurate for quantification of theophylline and salbutamol in pharmaceutical dosage form.
The sensitivity of instruments used for analysis of theophylline and salbutamol was expressed as limit of detection (LOD) and limit of quantification (LOQ). The values of LOD and LOQ were determined based on linear regression as in Miller and Miller (2005) . The LOD values for theophylline and salbutamol are 0.066 ppm and 0.295 ppm, respectively; while, LOQ values are 0.219 ppm and 0.991 ppm, respectively for theophylline and salbutamol. The developed method was subsequently used for assay of several pharmaceutical dosage forms that contains only theophylline or salbutamol as well as those contain both drugs (Table I ). The results showed that the evaluated syrup and tablet contained theophylline and salbutamol in the range as labelled.
CONCLUSION
Ion pair HPLC has been validated by determining several parameters including selectivity, linearity, precision, accuracy and sensitivity. The validation data obtained are acceptable. The developed method is successfully used for analysis of theophylline and salbutamol for syrup and tablet dosage forms which contain only theophylline or only salbutamol, as well as tablet containing the combination of theophylline and salbutamol.
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Syrup contains theophylline-salbutamol (SR-TS); Syrup contains theophylline (SR-TT); Syrup contains salbutamol (SR-ST); Tablet contains theophylline-salbutamol (TB-TS); tablet contains theophylline (TB-TT); tablet contains salbutamol (TB-ST).
